Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast...
On June 1, the U.S. Food and Drug Administration (FDA) approved a liquid biopsy test, a companion diagnostic test...
As a physician-scientist specializing in melanoma, Yvonne Saenger, MD, applies her frequent interactions with patients to her research and...
For the first time, the American Association for Cancer Research invited three cancer advocates from the AACR Scientist↔Survivor Program...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of cancer types for which immunotherapeutics known...
With warm weather finally here, bringing more people outdoors, it is important to remember that many cases of skin...
AACR President Nancy E. Davidson, MD, discusses her goals for her Presidential year at the AACR in an editorial...
Aime Franco, PhD, quietly battled cancer throughout her undergraduate years at the University of Connecticut. But even as she...
Late last week, the U.S. Food and Drug Administration (FDA) added another antiangiogenic therapeutic to the armamentarium for oncologists...
The lower premiums associated with high-deductible health plans may end up costing cancer patients in the long run.
We observe May as National Cancer Research Month to celebrate the tremendous advances that have been made in our...